Clinically known as benign prostatic hyperplasia (BPH), enlarged prostate is a non‑cancerous condition that affects roughly half of men ages 51 to 60, with incidence increasing ...

Dear Dr. Roach: My son, age 52, had recent lab results showing that his Lipoprotein (a) level was elevated, at 172 nmol/L. He is in very good health after a recent ablation for atrial fibrillation. We ...

Men suffering the symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH), now have access to a new treatment option at East Georgia Regional Medical Center.

UroLift may succeed in relieving your enlarged prostate symptoms and may allow you to stop taking medication. However, not ...

For Samantha Crausman, each day begins with a tiny reservoir of energy. Every activity — eating, listening, even thinking — drains that pool, forcing her to calculate how to expend it. If I talk to my ...

NYU Langone Health cited the “current regulatory environment” in its decision to discontinue its gender medicine program for minors. By Joseph Goldstein A major Manhattan hospital, faced with threats ...

CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them at risk for dangerous seizures or loss of consciousness due to severe low ...

The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...

TWO NEW CLINICAL trials at The Miriam Hospital are focused on prostate cancer treatments designed to precisely target prostate cancer cells while minimizing damage to healthy tissue. / COURTESY THE ...

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

The FDA has approved a new device to treat adults with locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel. The device called Optune Pax, is a portable, wearable ...